BridgeBio Pharma, Inc. 4

Chief Accounting Officer Maricel Apuli had 4,714 BridgeBio Pharma (BBIO) shares withheld for taxes upon RSU vesting, leaving her with 122,687 shares owned.

On August 16, 2026, Chief Accounting Officer Maricel Apuli had 4,714 shares of BridgeBio Pharma, Inc. common stock withheld by the issuer at an implied price of $79.86 per share, totaling approximately $376,500 in value, solely to satisfy tax obligations arising from the vesting of 9,262 RSU-based common shares. This Form 4 reflects a routine, non-discretionary tax withholding transaction rather than an open-market sale, and following the withholding, Apuli reported beneficial ownership of 122,687 shares of BridgeBio common stock.

Filing Facts

CIK

1743881

Ticker

BBIO

Form

4

Source Type

fda

Accession

0001470831-26-000835

Alert Tier

5